Azerbaijan vs Djibouti: Protecting minority investors: Strength of minority investor
Azerbaijan
25 DB15-20 methodology
in 2019
Djibouti
26 DB15-20 methodology
in 2019
Azerbaijan rank
105th
Djibouti rank
103rd
Protecting minority investors: Strength of minority investor over time
- Azerbaijan
- Djibouti
How they compare
Djibouti currently reports 26 DB15-20 methodology against 25 DB15-20 methodology in Azerbaijan, a difference of 1 DB15-20 methodology.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Azerbaijan ahead.
Azerbaijan ranks 105th and Djibouti ranks 103rd of 191 countries.
Azerbaijan has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, Azerbaijan or Djibouti?
- Djibouti, at 26 DB15-20 methodology against 25 DB15-20 methodology in Azerbaijan as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between Azerbaijan and Djibouti?
- 1 DB15-20 methodology, with Djibouti ahead.
- How many years of comparable data are there for Azerbaijan and Djibouti?
- 7 years are reported by both, from 2013 to 2019.
- How do Azerbaijan and Djibouti rank globally for protecting minority investors: strength of minority investor?
- Azerbaijan ranks 105th and Djibouti ranks 103rd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.